Digel Pharmaceuticals announced that the company signed a “License Agreement” with AstraZeneca on July 14, 2026, granting AstraZeneca the exclusive right to develop and commercialize Schwarzer worldwide. The agreement officially came into effect on August 31, 2026. Recently, the company received a $600 million down payment from AstraZeneca.

Zhitongcaijing · 1d ago
Digel Pharmaceuticals announced that the company signed a “License Agreement” with AstraZeneca on July 14, 2026, granting AstraZeneca the exclusive right to develop and commercialize Schwarzer worldwide. The agreement officially came into effect on August 31, 2026. Recently, the company received a $600 million down payment from AstraZeneca.